Brussels is under attack! The EU’s attacks on the UK vaccine “will have resulted in deaths.”


Brussels is under attack! The EU’s attacks on the UK vaccine “will have resulted in deaths.”

SENIOR As a result of deceptive statements made regarding the Oxford-AstraZeneca coronavirus vaccine, European authorities have been accused of having “blood on their hands.”

Independent trials have indicated that the AstraZeneca COVID-19 vaccine, produced in the United Kingdom, is both safe and effective in avoiding COVID-19 hospitalizations and deaths.

Key personalities such as French President Emmanuel Macron, on the other hand, were eager to cast doubt on the AstraZeneca vaccine’s efficacy, wrongly claiming that the Oxford-AstraZeneca vaccine “is quasi-ineffective on people older than 65, some say those 60 years or older.”

Author Bryan Appleyard, writing in the Sunday Times, ripped the bloc apart for its attitude about the jab.

“The European leaders who demolished the AstraZeneca vaccine have blood on their hands,’ a British government official was quoted as saying.

“It has to be true: the delays will have resulted in deaths, and false charges will have deterred people from getting the vaccine.

“Furthermore, any announcement suggesting there’s something wrong with the research will excite all those sad, naive anti-vaxxers.”

“How has this happened?” the author wondered, referring to poor immunization rates in Africa despite the vaccine’s effectiveness. The EU, according to that unidentified insider, is to blame: ‘They did it out of hatred for Britain because of Brexit.’

AstraZeneca, unlike several of its competitors, sold vaccines for cost, making “no profit” on the deals.

The EU filed a lawsuit against AstraZeneca in April, alleging that it had failed to fulfill a contract for coronavirus vaccinations.

The British-Swedish firm retaliated, stating that the lawsuit is “without merit” and that they provided to the EU “in accordance with our forecast.”

AstraZeneca is now “exploring options” for its coronavirus vaccine business, according to the Daily Telegraph, which might lead to a trade sale.

AstraZeneca’s biopharmaceuticals leader, Ruud Dobber, has stated that the company is “exploring other options” for future vaccine development.

Hannah Bolland, a pharmaceutical industry expert, cautioned that the corporation might have to exit the industry.

“The damage wrought by Europe’s assault on AstraZeneca is finally becoming obvious,” she said.

Northern Ireland accounts for around 20% of the EU’s external border inspections, underlining the daily disruption created by post-Brexit trade laws in the region.

According to sources on the ground, authorities in the area handled 20% of all shipments requiring agri-food checks and controls.

It is a statistic. “Brinkwire News in Condensed Form.”


Comments are closed.